IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Guenter Neef

USPTO Granted Patents = 12

Average Co-Inventor Count = 5.5

ph-index = 7

Forward Citations = 120(Granted Patents)


Company Filing History:

goldMedal12 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1978-2007

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7211680 - Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2007-05-01),
2. 6596713 - Steroid esters and amides, process for their production and their pharmaceutical use (2003-07-22),
3. 5446036 - 13-alkyl-11beta-phenylgonanes (1995-08-29),
4. 5273971 - 13-alkyl-11.beta.-phenylgonanes (1993-12-28),
5. 5132299 - 11.beta.-phenyl-4,9,15-estratrienes, their manufacture and (1992-07-21),
6. 4870069 - 11.beta.-alkynyl-estrenes and -estradienes, their production and (1989-09-26),
7. 4870067 - Oxytocins and antigestagens in combination for induction of birth (1989-09-26),
8. 4843157 - 13alpha-alkylgonan-delta 9(11)-5,10-epoxides (1989-06-27),
9. 4829060 - 11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and (1989-05-09),
10. 4596808 - Pharmacologically active 3-substituted beta-carbolines useful as (1986-06-24),
11. 4536401 - 11.beta.-aryl estradienes, processes for their production and (1985-08-20),
12. 4066674 - Process for the preparation of 1,3-oxygenated 8.alpha.-estratrienes and (1978-01-03),

Introduction

Guenter Neef, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of medicinal chemistry. With a portfolio of 12 patents, Neef is recognized for his pioneering work in developing novel vitamin D derivatives and steroid compounds that have potential therapeutic applications.

Latest Patents

Neef's latest patents include innovative methods for the production of vitamin D derivatives with carbo- or heterocyclic substituents at C-25. These compounds are particularly noteworthy for their pharmacological efficacy, potentially treating hyperproliferative skin diseases, tumor-related conditions, autoimmune disorders, and a range of other health issues including diabetes mellitus type II and osteoporosis. In addition to vitamin D derivatives, Neef has developed steroid esters and amides along with their pharmaceutical applications, pushing the boundaries of current medical treatments.

Career Highlights

Guenter Neef has been instrumental in advancing medicinal research while working at Schering Aktiengesellschaft, a leading pharmaceutical company. His innovative approaches in creating new chemical compounds have positioned him as a key player in the industry, particularly in the realm of therapy-related inventions.

Collaborations

Throughout his career, Neef has collaborated with esteemed colleagues, including Sybille Beier and Walter Elger. These partnerships have bolstered his research efforts, enabling a collective advancement in the understanding and application of innovative medicinal compounds.

Conclusion

Guenter Neef continues to impress with his dedication to scientific innovation and his significant contributions to the pharmaceutical field. His work not only enhances our understanding of complex diseases but also offers new hope for effective treatments through the development of groundbreaking compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…